Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma
Status:
Unknown status
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test the efficacy and tolerability of a multiagent
chemotherapy treatment regimen without radiotherapy in patients with newly diagnosed lymphoma
in the brain.
Phase:
Phase 2
Details
Lead Sponsor:
University of Aarhus
Collaborators:
Mundipharma Pte Ltd. Nordic Cancer Union Roche Pharma AG Schering-Plough